Prospective Evaluation of the Decision Aid for Bladder Cancer to Reduce Decision Conflict and Enhance Health Literacy in Patients with Bladder Cancer.

Prospective Evaluation of the Decision Aid for Bladder Cancer to Reduce Decision Conflict and Enhance Health Literacy in Patients with Bladder Cancer. - ProAID-B

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00034753

Enrollment

150

Registered

2025-09-01

Start date

2024-12-01

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C67.0 C67.1 C67.2 C67.3 C67.4 C67.5 C67.6 C67.7 C67.8 C67.9

Interventions

Group 1: Interventional Tool: “Decision Aid for Bladder Cancer” and Survey

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: - Patients with high-risk non-muscle invasive urothelial carcinoma of the bladder (according to EORTC classification) before initiating definitive therapy - Patients with muscle-invasive urothelial carcinoma of the bladder before initiating definitive therapy - Consent to participate in the study - Ability to use a digital device (independently or at least with a relative)

Exclusion criteria

Exclusion criteria: - Patients unable to give consent - Patients under legal guardianship - Patients with low-risk non-muscle invasive urothelial carcinoma of the bladder (according to EORTC classification) - Patients with intermediate-risk non-muscle invasive urothelial carcinoma of the bladder (according to EORTC classification) - Patients with high-risk non-muscle invasive urothelial carcinoma of the bladder (according to EORTC classification) after initiating therapy - Patients with muscle-invasive urothelial carcinoma of the bladder after initiating therapy

Design outcomes

Primary

Measure	Time frame
Descisional conflict	—

Secondary

Measure	Time frame
Emotional distress, disease-specific knowledge and user-friendliness of the interactive tool	—

Countries

Germany

Contacts

Public ContactNicolas Carl

Klinik für Urologie und Urochirurgie, Universitätsmedizin Mannheim

nicolas.carl@umm.de+496213832235

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026